Featured Stories
Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...
FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

FDA Warns about Counterfeit Decorative Contact Lenses

With Halloween just around the corner, the U.S. Food and Drug Administration (FDA) is warning about the risks associated with counterfeit decorative contact lenses. In a collaborative effort with the U.S. Immigration and Customs Enforcement’s Homeland Security Investigations and U.S. Customs and Border Protection, the FDA’s Office of Criminal Investigations is increasing efforts to seize fake contact lenses. Illegally imported counterfeit contact lenses are not FDA-approved, and can lead to serious injuries and blindness in users.

The ICE-led National Intellectual Property Rights Coordination Center in Washington is coordinating these efforts, which is called “Operation Double Vision.” There have been 74 seizures including a total of over 20,000 pairs of counterfeit and decorative contact lenses this year alone thanks to Operation Double Vision. Continue reading

Posted in Legal News |

Jury Finds Guardrail Maker Cheated Government

This week a Texas jury found that Trinity Industries defrauded the government by deliberately withholding information about changes to its ET-Plus highway guardrail system that potentially made it more dangerous. The company faces a potential liability of $1 billion.

The jury found the guardrail maker cheated the government of $175 million by passing off the product as eligible for federal funding, Insurance Journal reports. The damages awarded will be tripled and a penalty determined by the judge will be added – with total liability possibly reaching $1 billion, according to company attorneys. Continue reading

Posted in Accident, Defective Products |

Takata Air Bag Recall Affects 7.8 Million Vehicles

The owners of 7.8 million Toyota, Honda, Mazda, BMW, Nissan, Mitsubishi, Subaru, Chrysler, Ford and General Motors vehicles have been told to “act immediately” on recall notices to replace faulty air bags supplied by Takata. The parts should be replaced because they can explode, the National Highway Traffic Safety Administration (NHTSA) warned. According to TIME magazine, the faulty air bags have been linked to at least three deaths and over 100 injuries.
Continue reading

Posted in Legal News |

Motion to Consolidate Xarelto Bleeding Side Effects Cases in Multidistrict Litigation

Xarelto-Bleeding-Side-EffectsPlaintiffs who allege they were injured by the blood thinner Xarelto have filed a motion to have their cases consolidated as part of a multidistrict litigation (MDL).

At least 21 actions pending in 10 judicial districts make similar allegations against the manufacturers of Xarelto (rivaroxaban), a medicine prescribed to prevent or treat blood clots and reduce the risk of stroke. An MDL coordinates proceedings in complex litigation where a large number of lawsuits allege similar injuries associated with a medication or product. The motion requests the U.S. Joint Panel of Multidistrict Litigation (JPML) to assign the MDL to the Southern Illinois District, which handled the recent MDL involving another new anticoagulant, Pradaxa. Continue reading

Posted in Defective Products, Pharmaceuticals, Pradaxa |

Motion Filed to Consolidate Xarelto Lawsuits into MDL

Xarelto_LawsuitsThe anticoagulant Xarelto has raised a number of safety concerns in the short time it has been on the market. A number of lawsuits have been filed alleging that Bayer hid the risks of the drug, including an increased risk of bleeding. Now, a motion has been filed to consolidate the lawsuits into a multidistrict litigation (MDL).

The U.S. Joint Panel of Multidistrict Litigation (JPML) should centralize cases in the Southern District Illinois court, the motion stated. Plaintiffs said that the court is an ideal venue because it has has experience with the recent MDL over Pradaxa, another new bloodthinner. In a hearing that will take place either late this year or early next year, the JPML will hear arguments on the motion. Continue reading

Posted in Legal News |

Toyota Recalls 1.67 Million Vehicles Worldwide

Toyota_Recalls_1.67_Million_VehiclesToyota Motor Corp. has announced the recall of 1.67 million vehicles worldwide over safety defects, including faulty brakes and fuel components.

A Toyota representative said the company is not aware of any accidents or injuries related to the defects. The recall involves 1 million vehicles in Japan and 615,000 in other countries, Law360 reports. Fuel delivery pipe problems affect 759,000 vehicles and 802,000 others have brake issues. In addition, 190,000 Corolla Rumion and Auris models in Japan will be recalled because of faulty emission control components. All of the recalled vehicles in the United States are Lexus sedans with potentially leaky fuel pipes, which could cause the cars to catch fire, the Toyota representative said. Continue reading

Posted in Defective Products, Motor Vehicles, Product Recalls, Recalled Vehicles, Toyota Recall |

Study: Significant Number of Medication Errors Occur in Young Children

Medication-Errors-Occur-in-Young-ChildrenAccording to a study published in the journal Pediatrics, medication mistakes among young children occur more frequently than some would imagine. The study, which was based on calls to poison control hotlines, found that a medication mistake occurred in a child roughly every eight minutes from 2002 through 2012. The authors state that medication mistakes can lead to injury and sometimes death, in addition to increasing healthcare spending.

Researchers saw an increase in the rate of reported medication errors during the 11-year time frame of the study. The exception to this was cough and cold medicines. Henry Spiller, an author of the study and director of the Central Ohio Poison Center at Nationwide Children’s Hospital in Columbus, told Reuters Health that this decrease was preceded by a multipronged campaign to reduce the use of these products in children. The findings suggest that education has been successful in this effort. “We think that multipronged effort had an effect,” said Spiller to Reuters Health. “We can see a drop associated with these efforts.” Continue reading

Posted in Legal News |

New Jersey Appeals Court Considering Facebook Ethics Case

Facebook_Ethics_CaseA New Jersey appeals court is considering whether the Office of Attorney Ethics has the power to file ethics grievances against lawyers after district ethics committees have declined to do so, and whether the judges themselves even have the authority to get involved in the dispute.

If the panel decides that the Superior Courts can exercise jurisdiction over ethics matters, it will then have to decide whether OAE Director Charles Centinaro violated the rules governing the disciplinary process when he filed a complaint against two lawyers in Hackensack, after District II-B Ethics Committee secretary Doris Newman concluded their actions did not constitute unethical conduct, New Jersey Law Journal reports. Continue reading

Posted in Legal News |

Limited Data Available on Medication Dosage for Kids

Medication_Dosage_for_KidsWhen it comes to prescribing medication for children, there is often little data to support information about dosage, safety or efficiency. According to Scientific American, most clinical trials do not include children so the burden of deciding what treatments to use and how falls on physicians.

Scientific American reports that only 46 percent of drugs used in kids have been approved by the U.S. Food and Drug Administration (FDA) for pediatric use. In the past, that statistic was far worse. Continue reading

Posted in Legal News |

Trinity Industries Accused of Hiding Failed Crash Tests in Whistleblower Trial over Guardrails

Trinity_Industries_Accused_of_Hiding_Failed_Crash_TestsIn a trial over its guardrails, Trinity Industries was questioned about why they did not tell authorities about five failed crash tests. The New York Times reports that the case was filed under the False Claims Act by a competitor who alleged that the company violated federal rules when it failed to notify the Federal Highway Administration that it modified the design of its ET-Plus rail head in 2005.

These guardrails are the subject of the safety concerns outside of this federal lawsuits, according to The New York Times. Last month, the states of Missouri and Massachusetts banned the design and began their own investigations. Virginia also took issued with Trinity, and said in a letter that it believes the company failed to adequately test the ET-Plus. The state wants further testing. Continue reading

Posted in Legal News |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.